We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Asbury Automotive
ABG
$3.76B
| $413K | ﹤0.01% |
2,735
-12,484
| -82% | -$2.13M |
|
977
Novanta
NOVT
$6.35B
| $413K | ﹤0.01% |
3,570
-2,145
| -38% | -$292K |
|
978
Terex
TEX
$7.77B
| $413K | ﹤0.01% |
13,900
+1,678
| +14% | +$54.9K |
|
979
Amneal Pharmaceuticals
AMRX
$6.11B
| $410K | ﹤0.01% |
202,995
-1,340
| -0.7% | -$3.75K |
|
980
Varonis Systems
VRNS
$4.94B
| $410K | ﹤0.01% |
15,448
| – | – |
|
|
SLCA
981
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $410K | ﹤0.01% |
37,460
+13,084
| +54% | +$166K |
|
|
HONE
982
DELISTED
HarborOne Bancorp
HONE
| $409K | ﹤0.01% |
30,441
| – | – |
|
983
Liberty Latin America Class A
LILA
$1.67B
| $408K | ﹤0.01% |
96,915
-29
| -0% | -$140 |
|
|
PAMT
984
PAMT Corp
PAMT
$278M
| $408K | ﹤0.01% |
+13,169
| New | +$418K |
|
985
Tompkins Financial
TMP
$1.45B
| $406K | ﹤0.01% |
5,585
-300
| -5% | -$22.4K |
|
986
First Commonwealth Financial
FCF
$2.2B
| $398K | ﹤0.01% |
30,980
-1,500
| -5% | -$21K |
|
987
Arvinas
ARVN
$584M
| $397K | ﹤0.01% |
8,932
+1,469
| +20% | +$71.3K |
|
988
Northrop Grumman
NOC
$81.7B
| $397K | ﹤0.01% |
844
-10
| -1% | -$4.76K |
|
|
TSVT
989
DELISTED
2seventy bio
TSVT
| $397K | ﹤0.01% |
27,259
| – | – |
|
990
Sensient Technologies
SXT
$5.61B
| $396K | ﹤0.01% |
5,710
-10,670
| -65% | -$861K |
|
991
Capital One
COF
$137B
| $393K | ﹤0.01% |
4,269
+2,130
| +100% | +$227K |
|
|
FLIC
992
DELISTED
First of Long Island Corp
FLIC
| $393K | ﹤0.01% |
22,807
| – | – |
|
993
Rayonier Advanced Materials
RYAM
$563M
| $392K | ﹤0.01% |
124,380
| – | – |
|
994
Fulgent Genetics
FLGT
$521M
| $388K | ﹤0.01% |
10,183
-9,431
| -48% | -$473K |
|
|
UBA
995
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $388K | ﹤0.01% |
25,040
-18,587
| -43% | -$316K |
|
996
Cheesecake Factory
CAKE
$5.83B
| $386K | ﹤0.01% |
13,191
| – | – |
|
997
International Flavors & Fragrances
IFF
$21.6B
| $386K | ﹤0.01% |
4,251
| – | – |
|
998
Masco
MAS
$15B
| $383K | ﹤0.01% |
8,203
-2,700
| -25% | -$141K |
|
|
TMX
999
DELISTED
Terminix Global Holdings, Inc.
TMX
| $383K | ﹤0.01% |
9,995
| – | – |
|
1000
CNA Financial
CNA
$13.7B
| $382K | ﹤0.01% |
10,362
-575
| -5% | -$23.4K |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.